BioSpace News Archive

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement

Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and manufacture five candidate molecules, expanding upon the two companies’ existing CDO partnership first established in 2018.

July 15, 2020
·
2 min read
RaySearch and TAE Life Sciences Announce Agreement on RayStation Support for the Alphabeam System for BNCT

RaySearch Laboratories AB has entered into a licensing and distribution agreement with TAE Life Sciences, manufacturer of the Alphabeam™ System for boron neutron capture therapy.

July 15, 2020
·
2 min read
Business

West Announces Third-Quarter 2020 Dividend

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that the Company’s Board of Directors has approved a third-quarter 2020 dividend of $0.16 per share.

July 15, 2020
·
1 min read
Pharm Country

BD Supports U.S. Government Efforts to Increase COVID-19 Testing Capacity with Point-of-Care Tests

BD, a leading global medical technology company, announced a commitment from the U.S. Department of Health and Human Services to purchase BD diagnostic solutions in expanding access to rapid point-of-care testing for COVID-19 through a broad, decentralized network of testing instrumentation.

July 15, 2020
·
5 min read
Business

OpSens Announces Result for Q3 2020

Net earnings of $0.1 M for the third quarter ended May 31, 2020 compared with a net loss of $1.1 M for the corresponding period in 2019;

July 15, 2020
·
4 min read
Business

Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2020

Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product development across several market segments, announces that it will release its financial results for the second quarter 2020 on Wednesday, August 5, 2020.

July 15, 2020
·
3 min read
Pharm Country

Ansys 2020 R2 Accelerates Innovation For Engineering Teams

Leading-edge technologies and platform enhancements speed up collaborative design and expedite product delivery

July 15, 2020
·
6 min read
Deals

Caption Health Closes $53 Million Series B Round to Democratize Access to Ultrasound With the First and Only AI-Guided Ultrasound Technology

Accelerated Commercialization Due to COVID-19 Will Enable Providers to Offer Optimized, Efficient Care

July 15, 2020
·
4 min read
Policy

Knopp Biosciences Receives Rare Pediatric Disease Designation for Kv7 Activator KB-3061 for Treatment of KCNQ2 Epileptic Encephalopathy

Knopp Biosciences LLC announced that it has received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for its therapeutic candidate KB-3061, an activator of voltage-gated Kv7.2/7.3 potassium channels, for the treatment of KCNQ2 epileptic encephalopathy.

July 15, 2020
·
4 min read
BioMidwest

TherapeuticsMD and Nurx Expand Access to ANNOVERA®

Largest online practice for women’s health now offers the first FDA-approved long-lasting birth control method that does not require a medical procedure

July 15, 2020
·
10 min read